AREN2231

Risk Adapted Treatment of Unilateral Favorable Histology Wilms Tumors (FHWT)

Status:

OPEN TO ACCRUAL

Trial Type:
Age Group:
Both
Phase:

III

NCT Number:
Contact:

DeNardo, Bradley